ask="12.02"
ask_size="200"
average_daily_volume="1973210"
bid="11.37"
bid_size="200"
book_value="-0.09"
change="-0.98"
change_from_200_day_moving_average="1.42"
change_from_50_day_moving_average="0.47"
change_from_52_week_high="-3.53"
change_From_52_week_low="4.95"
change_in_percent="-7.60%"
close="11.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.74"
ex_dividend_date="N/A"
float_shares="94960000"
high="13.16"
high_52_weeks="15.44"
last_trade_date="1/11/2017"
last_trade_price="11.91"
last_trade_size="77043"
last_trade_time="4:00pm"
low="11.90"
low_52_weeks="6.96"
market_capitalization="1.53B"
moving_average_200_day="10.49"
moving_average_50_day="11.44"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.83"
pe_ratio="N/A"
peg_ratio="-0.31"
percent_change_from_200_day_moving_average="+13.50%"
percent_change_from_50_day_moving_average="+4.15%"
percent_change_from_52_week_high="-22.86%"
percent_change_from_52_week_low="+71.12%"
previous_close="12.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.33"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="15.05"
stock_exchange="NMS"
symbol="HALO"
volume="2929412"
weeks_range_52="6.96 - 15.44"
